145 related articles for article (PubMed ID: 34272229)
21. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
Kim N; Minn D; Park S; Roh EY; Yoon JH; Park H; Shin S
J Korean Med Sci; 2021 May; 36(21):e158. PubMed ID: 34060264
[TBL] [Abstract][Full Text] [Related]
22. Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance.
Pedersen RM; Tornby DS; Bistrup C; Johansen IS; Andersen TE; Justesen US
Clin Microbiol Infect; 2021 Sep; 27(9):1371-1373. PubMed ID: 34111582
[No Abstract] [Full Text] [Related]
23. Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study.
Yasin AI; Aydin SG; Sümbül B; Koral L; Şimşek M; Geredeli Ç; Öztürk A; Perkin P; Demirtaş D; Erdemoglu E; Hacıbekiroglu İ; Çakır E; Tanrıkulu E; Çoban E; Ozcelik M; Çelik S; Teker F; Aksoy A; Fırat ST; Tekin Ö; Kalkan Z; Türken O; Oven BB; Dane F; Bilici A; Isıkdogan A; Seker M; Türk HM; Gümüş M
Future Oncol; 2022 Mar; 18(10):1235-1244. PubMed ID: 35081732
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
[TBL] [Abstract][Full Text] [Related]
25. Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
Abbasi J
JAMA; 2022 Feb; 327(6):517. PubMed ID: 35133429
[No Abstract] [Full Text] [Related]
26. Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.
Addeo A; Shah PK; Bordry N; Hudson RD; Albracht B; Di Marco M; Kaklamani V; Dietrich PY; Taylor BS; Simand PF; Patel D; Wang J; Labidi-Galy I; Fertani S; Leach RJ; Sandoval J; Mesa R; Lathrop K; Mach N; Shah DP
Cancer Cell; 2021 Aug; 39(8):1091-1098.e2. PubMed ID: 34214473
[TBL] [Abstract][Full Text] [Related]
27. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
Werbel WA; Boyarsky BJ; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL
Ann Intern Med; 2021 Sep; 174(9):1330-1332. PubMed ID: 34125572
[No Abstract] [Full Text] [Related]
28. Antibody response following SARS-CoV-2 vaccination among patients with type 2 diabetes mellitus: A systematic review.
Soetedjo NNM; Iryaningrum MR; Lawrensia S; Permana H
Diabetes Metab Syndr; 2022 Feb; 16(2):102406. PubMed ID: 35104750
[TBL] [Abstract][Full Text] [Related]
29. Scent of a vaccine.
Lund FE; Randall TD
Science; 2021 Jul; 373(6553):397-399. PubMed ID: 34437109
[No Abstract] [Full Text] [Related]
30. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
31. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
[TBL] [Abstract][Full Text] [Related]
32. Vaccine trials ramp up in children and adolescents.
Couzin-Frankel J
Science; 2021 Feb; 371(6532):874-875. PubMed ID: 33632828
[No Abstract] [Full Text] [Related]
33. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
34. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.
Schwartz A; Nir O; Toussia-Cohen S; Leibovich L; Strauss T; Asraf K; Doolman R; Sharabi S; Cohen C; Levin EG; Lustig Y; Regev-Yochay G; Yinon Y
Am J Obstet Gynecol; 2021 Nov; 225(5):577-579. PubMed ID: 34352250
[No Abstract] [Full Text] [Related]
35. Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Fendler A; Shepherd STC; Au L; Wilkinson KA; Wu M; Schmitt AM; Tippu Z; Farag S; Rogiers A; Harvey R; Carlyle E; Edmonds K; Del Rosario L; Lingard K; Mangwende M; Holt L; Ahmod H; Korteweg J; Foley T; Barber T; Emslie-Henry A; Caulfield-Lynch N; Byrne F; Shum B; Gerard CL; Deng D; Kjaer S; Song OR; Queval C; Kavanagh C; Wall EC; Carr EJ; Namjou S; Caidan S; Gavrielides M; MacRae JI; Kelly G; Peat K; Kelly D; Murra A; Kelly K; O'Flaherty M; Shea RL; Gardner G; Murray D; Yousaf N; Jhanji S; Van As N; Young K; Furness AJS; Pickering L; Beale R; Swanton C; ; Gandhi S; Gamblin S; Bauer DLV; Kassiotis G; Howell M; Nicholson E; Walker S; Wilkinson RJ; Larkin J; Turajlic S;
Cancer Cell; 2022 Feb; 40(2):114-116. PubMed ID: 34968417
[No Abstract] [Full Text] [Related]
36. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
[TBL] [Abstract][Full Text] [Related]
37. Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis.
Hua T; Fan R; Fan Y; Chen F
Hum Vaccin Immunother; 2024 Dec; 20(1):2357424. PubMed ID: 38785118
[TBL] [Abstract][Full Text] [Related]
38. First case of postmortem study in a patient vaccinated against SARS-CoV-2.
Hansen T; Titze U; Kulamadayil-Heidenreich NSA; Glombitza S; Tebbe JJ; Röcken C; Schulz B; Weise M; Wilkens L
Int J Infect Dis; 2021 Jun; 107():172-175. PubMed ID: 33872783
[TBL] [Abstract][Full Text] [Related]
39. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
Kamar N; Abravanel F; Marion O; Couat C; Izopet J; Del Bello A
N Engl J Med; 2021 Aug; 385(7):661-662. PubMed ID: 34161700
[No Abstract] [Full Text] [Related]
40. Persistent Immunogenicity of the mRNA COVID-19 Vaccine in Patients Vaccinated Before Kidney Transplant.
Yi SG; Eagar T; Moore L; Huang HJ; Ibrahim H; Hobeika MJ; McMillan R; Podder H; Ghobrial RM; Gaber AO; Knight RJ
Transplantation; 2021 Oct; 105(10):e133-e134. PubMed ID: 34155187
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
